[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-RCKT":3,"homepage-market-summary":30,"stock-news-RCKT":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"RCKT","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Rocket Pharmaceuticals, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.","202","New York, NY",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":19,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},2.535,2.45,2.64,2.42,2.48,0.055,2.22,2808347.19703,14335,2.5538,5.45,2473476.820253203,3.8,2927,{"status":31,"indices":32,"watchlist":75,"sectors":97,"benchmarks":152},"success",[33,40,47,54,60,67],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":14,"sparkline":39,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":14,"sparkline":46,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":14,"sparkline":53,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":38,"is_up":14,"sparkline":59,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":14,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":73,"sparkline":74,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":14,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":73,"sparkline":89,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":14,"sparkline":96,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[98,103,108,113,118,123,128,133,138,142,147],{"name":99,"etf":100,"change":101,"price":102,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":104,"etf":105,"change":106,"price":107,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":109,"etf":110,"change":111,"price":112,"is_up":73},"Healthcare","XLV",1.03,168.81,{"name":114,"etf":115,"change":116,"price":117,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":119,"etf":120,"change":121,"price":122,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":124,"etf":125,"change":126,"price":127,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":129,"etf":130,"change":131,"price":132,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":134,"etf":135,"change":136,"price":137,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":139,"etf":140,"change":65,"price":141,"is_up":14},"Real Estate","XLRE",40.57,{"name":143,"etf":144,"change":145,"price":146,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":148,"etf":149,"change":150,"price":151,"is_up":14},"Comm Services","XLC",-0.35,111.26,[153,158,163,168],{"ticker":154,"name":155,"price":156,"change":157,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":159,"name":160,"price":161,"change":162,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":164,"name":165,"price":166,"change":167,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":169,"name":170,"price":171,"change":65,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":173,"articles":174},20,[175,181,187,193,199,205,211,217,223,229,234,239,245,250,255,260,266,271,276,281],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"Five of six patients had lower heart muscle measurements about 3 to 7 years after gene therapy. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQbkprcFNnbFpWanlnR2NIZ0dRM2wtTmhlbURrSFVQbHJqUW84ODhQTEI5QnBBS1FfS0p4dHZJOGhueVExaDJRZFJWTUJUeEFJNkJiS3JzWjBCR0JFQnJLalpqSVJlTjNxNExjUm5DSWY5NzFSOVhwakk0ekJBdTdIUkF4WVRKR09zakFEd3Bidm1mYWR6bkVVcURfOWY3QjlzREd0dFJ3VngzT2RVanpneUxJODIwUEc2V2VORjhYZw?oc=5","Wed, 07 Oct 2026 13:36:00 GMT","Five of six patients had lower heart muscle measurements about 3 to 7 years after gene therapy. Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data - Slideshow (NASDAQ:RCKT) 2026-10-07 - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxNc0s5bmt6ZkRyWHZBajFKZWd3Y083UXR2RS0wbGxzaC05VzFqT2k4anZ6clZkNThqeTdzbXlidUE5Q19PX290TTJEZVdzSjc0Z2hFbE5oNlpyMjFxQjIxUzlNQl9GSElNZ3RCOUxYQ2Y4TkFJVzJELWp3TEl4cTRyUkdhNFp5UWFZT3M3TmJrcWxMR01yS2t1eHctV2ZITlBuc1h1ZGpZUk9aUmxXamJhYW1obHdlMWs1N0FNQnppM1RycjVWZWZYREFXbjRkZw?oc=5","Wed, 07 Oct 2026 07:01:48 GMT","Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data - Slideshow (NASDAQ:RCKT) 2026-10-07 Seeking Alpha","Seeking Alpha",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Goldman Sachs Upgrades Rocket Pharmaceuticals (RCKT) to Neutral on RP-A501 Progress - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOeTRJX1FXdUQ2dmlmcmpXdUMxMVZESWFlNXk0aTVGbV9mclNBSXFEY0ZGb2ZYMU5IeWtNem1CX05LT0dKRExhSS1lZ0RjakpZUHJKelIxUXNLcTFPUVYzQkx3NVo2ZEMxZjVPU2ZPT2FxbUdYQ09rcXQxSEw2dVp4SUpDZ1gwa0duVWFPcDYzRDJXQVhiQ2JCU2lQRUJNY0lkUllyNmRHMmlZYjNKdGxWS05vdmY4M3pZOGow?oc=5","Thu, 08 Oct 2026 17:19:11 GMT","Goldman Sachs Upgrades Rocket Pharmaceuticals (RCKT) to Neutral on RP-A501 Progress GuruFocus","GuruFocus",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgJBVV95cUxPX1o4WVhzcFFDOTRVVFl5OEx1Y1Azc1QycTB4ekRXN0pPWWVGWFY3N1hNSUdPRjBQdWthTXZHQ21wRVU0WW9kRGo5UGRWUG1qRFhPX0RkRmJfeUphTHkwLURfYWpJZWthUFFXR0JGTW1BRHh6SmJobkl2bzdVUjF1ay1kc3NidlQ0bGFyYTdXcFdWNDRDQWcxRkx4V1hXNnJpWXpNWTZBR2JwZTI0ZUtzaDhUUGlnR3pyeURMV0NyUzBGek1UUUdIU1VqVG5nOV9XTndoQkxPLVo4TEpvREFhMTEyR2hJQkE4Q0ZoNVgwSkk1X2xKYkN2WC1POFpoQlpjQ2NiTjlLSUduckc5Q2laYU1IUUY4bmx1Tmc?oc=5","Sat, 03 Oct 2026 18:00:00 GMT","Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT) The Globe and Mail","The Globe and Mail",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility - Proactive financial news","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8gFBVV95cUxPRE1FVmFHRGY5SGR1dTAyZkNoYmJmNEk0VnJrTm9kYV9vbmJGUjJ4czF0QTNJV0JyckJxY2pJYU5IR1NlRzFYVzRSMlMydElqM2hyN0kxeFVrNnFhOVB3ZEVxc3FOQVJLclctTTNFeXhub0pXMFVyQWJrV3RId2F3Z3plUkZ4S3ZrWlVtcWszT25IcHFEQzRYaFF6NHg0Y3hQYkJYZWt5OHRsTVp2aHdkeFZDMzNSMWg4amR2aXllYzB0bndhcktDUG1tbF9yS1VFTjFxME50YTB3NGt1LW9jOVFkSHRBUHFSMS01RHNWaUZNZw?oc=5","Wed, 07 Oct 2026 11:36:00 GMT","Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility Proactive financial news","Proactive financial news",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Leerink Partners maintains Market Perform rating on Rocket Pharmaceuticals, $4 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxPMkdvMHc0WEhTV2VGdnpla0dtaU54VktMTkxJLVp6WkZvbW5mSkJudElCUHo0eTRDWmVJcmpVdTlySThOcjluN3hkYmZOMFpyNG93b3FNSDJfV1JPXzdiSTB2aHlDRElFMHRLR3NKaUo3bXhEdU1fa29UUEcydThMRTN6aF8yMV9ya2ZZbk5TZk1TWldxeUhEdEtYeWhrbGFINjNyRlpkQ1YyUzFwRkVXMjZrcWV0TDhmTVFqY1RiOV9MRGhraC1GdXh3MUFuQWZ5ZlljdFM5SDJNOXFsTGpRNWNkX080Zw?oc=5","Wed, 07 Oct 2026 17:01:06 GMT","Leerink Partners maintains Market Perform rating on Rocket Pharmaceuticals, $4 price target TradingView","TradingView",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Cantor Fitzgerald reiterates Rocket Pharmaceuticals stock rating By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxOSzFQUzJkT1ViNWd3amxudEZxZ0Vzb3JCNXpQNUpaaU51Sk5aVndfTWZQa002LUxaQm50Ql9UOVRtT3FMai13aVVFU0xLenlzMk5xNXBXdGlNSDVzOHhhVWpMbWpDRkpmUmpiNTVfbkpxTW1WYTZHT2R1S2R0NW54WG1aWmdsQ0s0SXlfSFlOaEkyWkMwclVfSElZMUJ1VjFzUWYwYnVlRVlhZ2pCa1JpS0pGd1B2OU1FR0JIOEZtdEpuT3c?oc=5","Wed, 07 Oct 2026 11:53:30 GMT","Cantor Fitzgerald reiterates Rocket Pharmaceuticals stock rating By Investing.com Investing.com India","Investing.com India",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2wFBVV95cUxPQXczTGFyckNUX2lhd05nbUNkN2VLRnhIY2U2TksyVWV4bnhOdjZzeElTa2EzY2NzLXR1VGFJenJCR0N6QVVkTHNwWWRiTWFhYjA4UDdBYlN6SlZrVmVvVWpuWHNRWVRQOVBWQTNVdGVNOGZia05BWWQyaXFlY1ZKcmV6QzYweGdTV21EN3Z6M19LSjlidWNvMUszbmRlSEtrcFpMdUJJTk5obU1EMWRvWmx0a2VILUZUcFBtV0hublQ1QVpEaTZyQnFRazhyQTk4bHpNQ1ZfYmE0UTQ?oc=5","Thu, 08 Oct 2026 12:29:13 GMT","This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday Benzinga","Benzinga",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"Rocket Pharmaceuticals Shares Rise After Goldman Sachs Upgrade - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxPNVBjTDEyV1VQVm1Gek1zUXlaZkloZUNLZ2pZWk5VUWpoUzhacGJMX1JYWTFXUlU0R2xNV29FUU1BaEpTYV9pcFRuOTRsOTN3ckdCeTlBQjVDRGZYM3dnQ1ZZZXVoQzd6VlV6a3NOazBXMV9YNnRDTWIzOWxKRk55dDM2UUZXNUNlV01ITHY0UjA4TTdYYm5UeC1pWnlYN1BLdngzT19tTlRLMzBXRmljcV9waW9pQQ?oc=5","Thu, 08 Oct 2026 19:12:28 GMT","Rocket Pharmaceuticals Shares Rise After Goldman Sachs Upgrade marketscreener.com","marketscreener.com",{"title":230,"link":231,"pubDate":232,"description":233,"source":192},"RCKT Reiterates by Wedbush -- Price Target Maintained at $15.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxObUJrUDNpWWctRWZJQ2lybmdseGhZbFVQclRyc3Z3NWtzZVVvTlNJQ1Z6WEtYVnlqRFFkX2JGZHBNZlg5WllrM3dkTW5xcVFubS1CNFFYZVloTTRFc29ha2dBQmgyNERKV3l4VGwzc0NJNnVaUDUwWm5qRjFSclhZdEZFYVRKTWdMR0pjb1V6VnFrMkd6aFY2SWU5NXdNdw?oc=5","Wed, 07 Oct 2026 17:02:42 GMT","RCKT Reiterates by Wedbush -- Price Target Maintained at $15.00 GuruFocus",{"title":235,"link":236,"pubDate":237,"description":238,"source":186},"Rocket Pharma updates progress on RP-A501 for Danon disease - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxQU1pOWHJrQjctZWZNTWdjbDczWVdfQndxaUIwd3BrTjRURkZnS3ZhcnVSU3lXRHJfbi1QVDltM2FndDg0NE1zb1YyaFZaYmtLaVJRWHFvMDNUT01KbUNPaGF2MjU5YWZmRTNKalBwU0tiUEg1WGROMDVQYnlmRF9XeUVMaFpnVlVJVVlqQzIySXZFdnVZ?oc=5","Wed, 07 Oct 2026 15:44:22 GMT","Rocket Pharma updates progress on RP-A501 for Danon disease Seeking Alpha",{"title":240,"link":241,"pubDate":242,"description":243,"source":244},"Jefferies cuts Rocket Pharmaceuticals stock price target on timeline By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPaERGeHZQLUxpa2dQdmZ3WmRlR3UzYWtCVXVPVXBfbm5MSDBscjBoOExXNkpWOS1tMjNGOWtFbUxCMGtPM1ctV2ZvQS0xeEFNS1ZQMWpVeVhRVzF2ZXJsSEJkQnJXcy1DSW50emsxTG1PS2xPeEZXWnh6VWh1bjBwampidEwwMUM4a2JpazBicldSc2c3QnJKSTIyNmo5bTJEMHNfUEZOUGo4ZVlJNlI4OTJQSDdoSEpxVWtBQ3Z5ZmN5OU10NjEzSQ?oc=5","Wed, 07 Oct 2026 14:25:39 GMT","Jefferies cuts Rocket Pharmaceuticals stock price target on timeline By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":246,"link":247,"pubDate":248,"description":249,"source":192},"Rocket Pharmaceuticals (RCKT) Advances Danon Disease Phase 2 Tri - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPMWFTY0hYT0s5clNKcGNFc3ZJMlVRQi0xVDlxZy10d0pzOHlLYzltaFdEaVQyUFFOYWU0WDk5OC1TLWZOUHphLThTMlF5SzMxdFZrRVhFUnUxcTVXMXNJUFFDV0hjSTlrZVctX1hvM0JtRXFCNm9ka0w3amJEcXV0ZDAxNkNhLTNjVldDbUhnVThCenRNM3pPWVRscTAyYnNMcWhvUGxnNEZJUkNRNW00bVJRZWZWMlpPaXduY3RTUVpDX1Jsc3dVbQ?oc=5","Wed, 07 Oct 2026 14:04:46 GMT","Rocket Pharmaceuticals (RCKT) Advances Danon Disease Phase 2 Tri GuruFocus",{"title":251,"link":252,"pubDate":253,"description":254,"source":210},"Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihAJBVV95cUxOc21uaU9hYnF5QlhTdzM1OWVBanZTTk5LTXY3aTZRcWxNVFA2dzdidWhIU3NYem5DUzM2STBtd2Zkb3J1eU1lTUgxS3lXak9UUFd1T0UwV0M3UlZCdE9leERZckJTaHBCdzVOMmx4djdkTVFob2hkM21uZ1l4REVubGxFSmFyR245R2FrdmVTLXlIa3J0RkI0TDdtQ0lzRUxlZTlXN1pzSDZiNHNMU243OWhhTEdiT1BvajRqblF1djZ4SENOYWlWUk1VV2dfSDNjRlJweU0wYXZxRnJXTGJWX1o3RFhsdkJ4SDhucWN1aWQ2eEw3cnpPcWRPMXhBclVvYUVJNQ?oc=5","Mon, 05 Oct 2026 03:09:00 GMT","Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist TradingView",{"title":256,"link":257,"pubDate":258,"description":259,"source":192},"RCKT Maintains Rating by Leerink Partners -- Price Target Lowered to $4.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxQTDBiZXZrQ2Z4ZGpLdEgxdHlrT2UxUF9TWUdULTJlTktLOU9vWjNKZ0Rkd3NOeWY1QjVIMklBUDA0eU1JMzNLdnRiS3pXazlHOVN5VTg5RjJQbW56TEp0SEFiZFV0eGRvSXZyczFfemd6QzJYeE9RUi13dDdYWUtNRjhIWVBpSWFFNmZxeWlQWXQ4NjVqZXBsRXY2dGhMWHNKbFRsNEZoMl9DX1FC?oc=5","Wed, 07 Oct 2026 17:59:39 GMT","RCKT Maintains Rating by Leerink Partners -- Price Target Lowered to $4.00 GuruFocus",{"title":261,"link":262,"pubDate":263,"description":264,"source":265},"Why is Rocket Pharmaceuticals stock up 3% today? By Investing.com - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxQODhxNF9VcVp5NWdSdHNNMmlVQlVCRGNKMHBwOXZhZFNISDN0Tzh4N0pYaGlLcXVLMDNrd2R3NmVjYmt5QU12X1ljWmVvU2RmeGF3SjlXNGFHSXAzaDhvTFljcEN1SVE4bEk5Zl95c1B5c1NELXktN19kd0JMS2pjUTE3UHcwSjVCaXFQejNRam9rWFptSkIwZUJmQlpMd2lHZllVQUR1dmtJekE?oc=5","Thu, 08 Oct 2026 08:50:00 GMT","Why is Rocket Pharmaceuticals stock up 3% today? By Investing.com Investing.com UK","Investing.com UK",{"title":267,"link":268,"pubDate":269,"description":270,"source":192},"RCKT Maintained by Chardan Capital -- Price Target Stays at $11 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinwFBVV95cUxQM3IxOTF5cGFTOXpxQTU4UVVKQUVEUzc0bmlLdHVSWlItajJRQ1F6bHhTRS1xLUgtbEJDdER2SVlOSDEzR0tRbmJYQVpOMHgxTXdCVnEwSDczVGlTYmNPNEVkcktrXzMtbGxjc3pVanltWGFOdUNZWXAwbVRTNjN6VEpKLTNrQzhBQ1NvOXdHRGotdDJyLVVJeEZWYkUzSGM?oc=5","Wed, 07 Oct 2026 13:37:57 GMT","RCKT Maintained by Chardan Capital -- Price Target Stays at $11 GuruFocus",{"title":272,"link":273,"pubDate":274,"description":275,"source":192},"Rocket Pharmaceuticals (RCKT) Advances Phase 2 Trial for Danon D - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPQmxHejYtVmdjZmg5WHU5R3VuUi1GSGNJaFI4VVVXUGxWM3JaSWN1TnZyRkhuMUlLTnZfOEFuUktLUjdyVlpIMUxNdW5GMlBGRHNHTU05QmVYVnB5OHE0QldQRXZ1YkRRbjVBMm0yak9xeUl3bTlVRXFadS00S3FfU2ROazY5ODZwZ3plNzlfQVVqV3Ryd2lQQ0RVRXpNbzJab0N3SndEZmpxZUFrZ3lWU3ZPek9GUmVKbjF6Ng?oc=5","Wed, 07 Oct 2026 17:42:47 GMT","Rocket Pharmaceuticals (RCKT) Advances Phase 2 Trial for Danon D GuruFocus",{"title":277,"link":278,"pubDate":279,"description":280,"source":192},"Rocket Pharmaceuticals, Inc. Comprehensive Danon Disease Program Webinar Transcript - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZ0FVX3lxTE1hMzduVXhRNHVscktZdjVuZjZLVU9lSmd1cU01ei1aNEU1elFtSXl3WkhhVlVXd2xTcHlSdGxwMVd1ZC1WU3M4S2wwT0hTS19WYjQyTnY5WFJ6c3NRcFRaN29jeF9HS0E?oc=5","Tue, 06 Oct 2026 20:30:00 GMT","Rocket Pharmaceuticals, Inc. Comprehensive Danon Disease Program Webinar Transcript GuruFocus",{"title":282,"link":283,"pubDate":284,"description":285,"source":286},"Rocket secures up to USD 150 million: what it means for Rocket Pharmaceuticals stock - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2gFBVV95cUxNZDAyb01acmZOS2NwSzhMb3l3Z0NPWkxNZ1ZSVV9Bc2FyYkFHUEQxZVVOY1BMdzd3WWJjbjNKNDNYbXd6ZzJsdUcxMUtpUmRIb21HeXFNZjM0VVhTZDIyeXdYQnBIUGU4cWNBNnFESnluN1BMVTdoQmc5MW9oZDM3VkZaM0d4UkgxODQ4VExEa2xrOEVKMjQ5X3k4REktYTN4QnhhaUFtYXEyX2dVLU96NVBnUTg5czc2b1JPT2RfZnBJTk1WYkZ4aVpVUktDa3JwQlJYUW8yY1ppUQ?oc=5","Wed, 07 Oct 2026 02:00:29 GMT","Rocket secures up to USD 150 million: what it means for Rocket Pharmaceuticals stock AD HOC NEWS","AD HOC NEWS"]